Kevin McCracken

Mr. McCracken is the Senior Vice President of CMC (Chemistry, Manufacturing and Controls) and is responsible for development, manufacturing and commercialization of Equilibre drug candidates. Mr. McCracken brings to Equilibre over 25 years of experience in biopharmaceutical and pharmaceutical drug development with roles in Analytical, Quality/Compliance, Validation, Manufacturing, Regulatory and Supply Chain. Mr. McCracken possesses depth of experience with small molecule, monoclonal antibodies, vaccines, blood-derived products as well as solid oral, oral liquid and sterile dose formulations. Mr. McCracken has been responsible for the advancement of clinical to commercial products with extensive experience in drug development strategy and interaction with regulatory agencies. Prior to joining Equilibre Mr. McCracken was the Chief Operating Officer for Noveome Biotherapeutics, overseeing manufacturing, clinical, quality, project management and regulatory operations. Prior to Noveome, Mr. McCracken worked for Kadmon, Acambis and MedImmune.

Mr. McCracken graduated from The University of Pittsburgh with a B.S. in Microbiology and holds an MBA from Frostburg University.